SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-194111
Filing Date
2024-08-06
Accepted
2024-08-05 18:32:31
Documents
13
Period of Report
2024-08-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d862743d8k.htm   iXBRL 8-K 22840
  Complete submission text file 0001193125-24-194111.txt   140491

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20240801.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20240801_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20240801_pre.xml EX-101.PRE 10807
15 EXTRACTED XBRL INSTANCE DOCUMENT d862743d8k_htm.xml XML 3498
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 241176436
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)